Stock WUHN WUHAN GENERAL GROUP (CHINA), INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Wuhan General Group (China), Inc.

Equities

WUHN

US9825691051

Market Closed - OTC Markets
Other stock markets
 19:46:40 02/02/2024 GMT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Wuhan General Group (China), Inc. -.--% -99.00%
2023 Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences CI
2022 Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN). CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
M2Bio Sciences Pharmacology and Clinical Application of CBD
AQ
Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences
CI
Wuhan General China : Announces Disposal
PU
Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).
CI
Wuhan General China : Annual disclosure and Financial Statements
PU
Wuhan General Group, Inc. reached an agreement to acquire a 40% stake in Tsime Pharmaceuticals Ltd from Bataung Likate and other shareholders.
CI
Wuhan General (China) : Quarterly Report 30 September 2021
PU
Wuhan General (China) : Quarterly Report 30 September 2021
PU
Wuhan General China : Group, Inc.
AQ
Wuhan General Group, Inc. Announces Appointment of Michael Sachar as CEO of M2bio Sciences Food &Beverage
CI
Wuhan General Group, Inc. announced that it expects to receive $0.45 million in funding from ThreeD Capital Inc.
CI
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
GL
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
GL
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa
GL
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa
CI
Wuhan General Group Appoints Distinguished Scientist Dr. Hyder A. Khoja as Chief Scientific Officer
GL
Wuhan General Group Appoints Hyder A. Khoja as Chief Scientific Officer
CI
Wuhan General Group, Inc. Announces Strategic Reorganization to Capitalize Medical Marijuana and Psilocybin Mushroom Industries; Appoints Luka Marjanovic as Head of Product Development for the MJ MedTech Division in South Africa
CI
Wuhan Provides Updates on Corporate, Psilocybin and Cannabis Q3 2019 Milestones
GL
Wuhan Expands Capacity to Produce Medicinal Marijuana and Mushrooms
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WUHN Stock
  4. News Wuhan General Group (China), Inc.